Results 51 to 60 of about 1,994,828 (407)

Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma

open access: yesThyroid, 2018
Anaplastic thyroid cancer (ATC) is a devastating disease with a dismal prognosis. Patients who have disease confined to the thyroid and who are able to undergo complete surgery and chemoradiation stand the best chance for survival.
M. Cabanillas   +12 more
semanticscholar   +1 more source

Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma?

open access: yesCancer Cytopathology, 2020
Ultrasound (US) risk stratification systems (RSSs) have been developed to reduce the number of unnecessary fine needle aspirations (FNAs) of thyroid nodules.
M. Castellana   +7 more
semanticscholar   +1 more source

Distribution of histopathological types of thyroid tumors in 1999-2015 compared to 1966-1988 year period [PDF]

open access: yesArchive of Oncology, 2020
Background: The most common thyroid tumors originate from the epithelial follicular cells. Etiology involved in the development of thyroid carcinoma is multifactorial, including external influences and genetic predisposition.
Makazlieva Tanja   +3 more
doaj  

Case reports of collision and composite carcinomas of the thyroid: an insight into their origin and clinical significance

open access: yesBMC Endocrine Disorders, 2023
Background Collision and composite carcinomas of the thyroid are extremely rare, and their clinical and biological characteristics are poorly understood.
Tao Ma   +6 more
doaj   +1 more source

Galectin-3 performance in histologic and cytologic assessment of thyroid nodules. A systematic review and meta-analysis [PDF]

open access: yes, 2017
The literature on Galectin-3 (Gal-3) was systematically reviewed to achieve more robust information on its histologic reliability in identifying thyroid cancers and on the concordance between Gal-3 test in histologic and cytologic samples.
Crescenzi, Anna   +4 more
core   +1 more source

LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma

open access: yesCell Death and Disease, 2018
Over the past decade, lncRNAs have been widely reported in human malignant tumors, including papillary thyroid carcinoma. LncRNA SNHG15 has been validated to be a tumor facilitator in several types of malignancies.
Dongdi Wu   +13 more
semanticscholar   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Potential functions and mechanisms of lysine crotonylation modification (Kcr) in tumorigenesis and lymphatic metastasis of papillary thyroid cancer (PTC)

open access: yesJournal of Translational Medicine
Objectives To examine the putative functions and mechanisms of lysine crotonylation (Kcr) during the development and progression of papillary thyroid cancer (PTC).
Zhaokun Li   +12 more
doaj   +1 more source

Diffuse sclerosing variant of thyroid carcinoma presenting as Hashimoto thyroiditis: a case report [Difuzno sklerozirajući oblik papilarnog karcinoma štitnjače nalik Hashimoto tireoiditisu: prikaz slučaja] [PDF]

open access: yes, 2012
The aim of report is to present a case of a rare diffuse sclerosing variant of a papillary thyroid carcinoma. A 15-year old girl referred for ultrasound examination because of painless thyroid swelling lasting 10 days before.
Banek, Tomislav   +4 more
core  

A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC [PDF]

open access: yes, 2015
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor mediating the toxicity and tumor-promoting properties of dioxin. AHR has been reported to be overexpressed and constitutively active in a variety of solid tumors, but few data
Barollo, Susi   +16 more
core   +4 more sources

Home - About - Disclaimer - Privacy